2010 Fiscal Year Self-evaluation Report
Targeting Survivin for hematological malignancies with activated Flt3
Project/Area Number |
20390298
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Shimane University |
Principal Investigator |
FUKUDA Seiji Shimane University, 医学部, 准教授 (30273147)
|
Project Period (FY) |
2008 – 2011
|
Keywords | 白血病 / Survivin / ITD-Flt3 / 分子標的 |
Research Abstract |
SurvivinがITD-Flt3により生ずる異常造血や白血病幹細(LSC)の自己複製や増殖に関わるかを明らかにする。更に、正常造血幹細胞(HSC)とITD-Flt3陽性LSCでのSurvivin下流分子群の違い、またこの経路を選択的にブロックすることによる治療戦略の可能性について検討し、より有効で安全なAML治療法開発の一助とする
|
Research Products
(13 results)
-
-
-
-
-
[Journal Article] The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin
Author(s)
Srirangam A, Milani M, Mitra R, Guo Z, Rodriguez M, Kathuria H, Fukuda S, Rizzardi A, Schmechel S, Skalnik DG, Pelus LM, Potter DA
-
Journal Title
Journal of Thoracic Oncology in press
Peer Reviewed
-
[Presentation] Survivin Modulates Gene Expression that Connect through an Extensive Functional Signaling Network And Regulates Proliferation of Hematopoietic Stem Cells through Evi-12010
Author(s)
Fukuda S, Singh P, Hoggatt J, Speth JM, Abe M, Conway EM, Crispino JD, Nucifora G, Yamaguchi S, Pelus LM.
Organizer
52^<nd> Annual Meeting of American Society of Hematology
Place of Presentation
Orlando, EL
Year and Date
2010-12-07
-
-
-
-
-
-
-